Prediction models for cardiovascular disease risk in the general population: systematic review

JAAG Damen, L Hooft, E Schuit, TPA Debray… - bmj, 2016 - bmj.com
Objective To provide an overview of prediction models for risk of cardiovascular disease
(CVD) in the general population. Design Systematic review. Data sources Medline and …

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart …

P Greenland, JS Alpert, GA Beller, EJ Benjamin… - Journal of the American …, 2010 - jacc.org
The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted for the period beginning March 2008 through …

Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants

AM Alaa, T Bolton, E Di Angelantonio, JHF Rudd… - PloS one, 2019 - journals.plos.org
Background Identifying people at risk of cardiovascular diseases (CVD) is a cornerstone of
preventative cardiology. Risk prediction models currently recommended by clinical …

Priority actions for the non-communicable disease crisis

R Beaglehole, R Bonita, R Horton, C Adams, G Alleyne… - The lancet, 2011 - thelancet.com
Summary The UN High-Level Meeting on Non-Communicable Diseases (NCDs) in
September, 2011, is an unprecedented opportunity to create a sustained global movement …

Hypertension in developing countries

MM Ibrahim, A Damasceno - The Lancet, 2012 - thelancet.com
Data from different national and regional surveys show that hypertension is common in
developing countries, particularly in urban areas, and that rates of awareness, treatment …

Growing epidemic of coronary heart disease in low-and middle-income countries

TA Gaziano, A Bitton, S Anand… - Current problems in …, 2010 - Elsevier
Coronary heart disease (CHD) is the single largest cause of death in the developed
countries and is one of the leading causes of disease burden in developing countries. In …

Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

AS Ishizuka, KE Lyke, A DeZure, AA Berry, TL Richie… - Nature medicine, 2016 - nature.com
Abstract An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ
Vaccine, is highly protective against controlled human malaria infection (CHMI) 3 weeks …

Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity

JE Epstein, K Tewari, KE Lyke, BKL Sim, PF Billingsley… - Science, 2011 - science.org
Our goal is to develop a vaccine that sustainably prevents Plasmodium falciparum (Pf)
malaria in≥ 80% of recipients. Pf sporozoites (PfSPZ) administered by mosquito bites are …

Predicting the 30-year risk of cardiovascular disease: the framingham heart study

MJ Pencina, RB D'Agostino Sr, MG Larson… - Circulation, 2009 - Am Heart Assoc
Background—Present cardiovascular disease (CVD) risk prediction algorithms were
developed for a≤ 10-year follow up period. Clustering of risk factors at younger ages and …

[HTML][HTML] Protection against Plasmodium falciparum malaria by PfSPZ Vaccine

JE Epstein, KM Paolino, TL Richie, M Sedegah… - JCI insight, 2017 - ncbi.nlm.nih.gov
BACKGROUND: A radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ)
malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf …